A Multidisciplinary Approach to Managing HCC

Program Overview

The management of unresectable hepatocellular carcinoma (HCC) involves recognizing and managing adverse events and effectively working with a multidisciplinary team. This Clinical ForumSM brings together an interventional radiologist, oncologist, and hepatologist to discuss how they work together at their institutions to achieve a common goal.

Credit Expired

Target Audience

This activity is designed to meet the educational needs of oncology providers, including physicians, nurse practitioners, and physician assistants who manage patients with hepatocellular carcinoma (HCC).

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Identify and manage adverse events associated with both targeted therapy and immune checkpoint inhibitors
  • Incorporate a multidisciplinary approach to the management of advanced hepatocellular carcinoma (HCC)

Activity Faculty


Ghassan K. Abou-Alfa, MD, MBA (Chair)

Memorial Sloan Kettering Cancer Center
New York, NY


Anne M. Covey, MD

Memorial Hospital for Cancer and Allied Diseases
New York, NY


Amit Singal, MD, MS

David Bruton Jr. Professor in Clinical Cancer Research
Associate Professor, Medicine
Medical Director, Liver Tumor Program
Clinical Chief, Hepatology
University of Texas Southwestern
Dallas, TX


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources